List of Tables
Table 1. Oncology Based Preclinical CRO Market Trends
Table 2. Oncology Based Preclinical CRO Market Drivers & Opportunity
Table 3. Oncology Based Preclinical CRO Market Challenges
Table 4. Oncology Based Preclinical CRO Market Restraints
Table 5. Global Oncology Based Preclinical CRO Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Oncology Based Preclinical CRO Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Oncology Based Preclinical CRO Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Oncology Based Preclinical CRO Product Type
Table 9. Key Companies Time to Begin Mass Production of Oncology Based Preclinical CRO
Table 10. Global Oncology Based Preclinical CRO Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Oncology Based Preclinical CRO Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Oncology Based Preclinical CRO Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Oncology Based Preclinical CRO Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Oncology Based Preclinical CRO Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Oncology Based Preclinical CRO Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Oncology Based Preclinical CRO Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Oncology Based Preclinical CRO Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Oncology Based Preclinical CRO Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Oncology Based Preclinical CRO Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Oncology Based Preclinical CRO Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Oncology Based Preclinical CRO Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Oncology Based Preclinical CRO Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Oncology Based Preclinical CRO Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Oncology Based Preclinical CRO Sales Value by Region (2019-2024) & (%)
Table 27. Global Oncology Based Preclinical CRO Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Oncology Based Preclinical CRO Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Oncology Based Preclinical CRO Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Oncology Based Preclinical CRO Sales Value, (2025-2030) & (US$ Million)
Table 31. Crown Bioscience Basic Information List
Table 32. Crown Bioscience Description and Business Overview
Table 33. Crown Bioscience Oncology Based Preclinical CRO Products, Services and Solutions
Table 34. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of Crown Bioscience (2019-2024)
Table 35. Crown Bioscience Recent Developments
Table 36. Charles River Basic Information List
Table 37. Charles River Description and Business Overview
Table 38. Charles River Oncology Based Preclinical CRO Products, Services and Solutions
Table 39. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of Charles River (2019-2024)
Table 40. Charles River Recent Developments
Table 41. ICON Basic Information List
Table 42. ICON Description and Business Overview
Table 43. ICON Oncology Based Preclinical CRO Products, Services and Solutions
Table 44. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of ICON (2019-2024)
Table 45. ICON Recent Developments
Table 46. Eurofins Scientific Basic Information List
Table 47. Eurofins Scientific Description and Business Overview
Table 48. Eurofins Scientific Oncology Based Preclinical CRO Products, Services and Solutions
Table 49. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of Eurofins Scientific (2019-2024)
Table 50. Eurofins Scientific Recent Developments
Table 51. Taconic Biosciences Basic Information List
Table 52. Taconic Biosciences Description and Business Overview
Table 53. Taconic Biosciences Oncology Based Preclinical CRO Products, Services and Solutions
Table 54. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of Taconic Biosciences (2019-2024)
Table 55. Taconic Biosciences Recent Developments
Table 56. Covance Basic Information List
Table 57. Covance Description and Business Overview
Table 58. Covance Oncology Based Preclinical CRO Products, Services and Solutions
Table 59. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of Covance (2019-2024)
Table 60. Covance Recent Developments
Table 61. EVOTEC Basic Information List
Table 62. EVOTEC Description and Business Overview
Table 63. EVOTEC Oncology Based Preclinical CRO Products, Services and Solutions
Table 64. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of EVOTEC (2019-2024)
Table 65. EVOTEC Recent Developments
Table 66. The Jackson Laboratory Basic Information List
Table 67. The Jackson Laboratory Description and Business Overview
Table 68. The Jackson Laboratory Oncology Based Preclinical CRO Products, Services and Solutions
Table 69. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of The Jackson Laboratory (2019-2024)
Table 70. The Jackson Laboratory Recent Developments
Table 71. MI Bioresearch Basic Information List
Table 72. MI Bioresearch Description and Business Overview
Table 73. MI Bioresearch Oncology Based Preclinical CRO Products, Services and Solutions
Table 74. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of MI Bioresearch (2019-2024)
Table 75. MI Bioresearch Recent Developments
Table 76. Champion Oncology Basic Information List
Table 77. Champion Oncology Description and Business Overview
Table 78. Champion Oncology Oncology Based Preclinical CRO Products, Services and Solutions
Table 79. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of Champion Oncology (2019-2024)
Table 80. Champion Oncology Recent Developments
Table 81. Wuxi AppTec. Basic Information List
Table 82. Wuxi AppTec. Description and Business Overview
Table 83. Wuxi AppTec. Oncology Based Preclinical CRO Products, Services and Solutions
Table 84. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of Wuxi AppTec. (2019-2024)
Table 85. Wuxi AppTec. Recent Developments
Table 86. Xentech Basic Information List
Table 87. Xentech Description and Business Overview
Table 88. Xentech Oncology Based Preclinical CRO Products, Services and Solutions
Table 89. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of Xentech (2019-2024)
Table 90. Xentech Recent Developments
Table 91. Living Tumor Laboratory Basic Information List
Table 92. Living Tumor Laboratory Description and Business Overview
Table 93. Living Tumor Laboratory Oncology Based Preclinical CRO Products, Services and Solutions
Table 94. Revenue (US$ Million) in Oncology Based Preclinical CRO Business of Living Tumor Laboratory (2019-2024)
Table 95. Living Tumor Laboratory Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Oncology Based Preclinical CRO Downstream Customers
Table 99. Oncology Based Preclinical CRO Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Oncology Based Preclinical CRO Product Picture
Figure 2. Global Oncology Based Preclinical CRO Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Oncology Based Preclinical CRO Sales Value (2019-2030) & (US$ Million)
Figure 4. Oncology Based Preclinical CRO Report Years Considered
Figure 5. Global Oncology Based Preclinical CRO Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology Based Preclinical CRO Revenue in 2023
Figure 7. Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Blood Cancer Picture
Figure 9. Solid Tumors Picture
Figure 10. Others Picture
Figure 11. Global Oncology Based Preclinical CRO Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Oncology Based Preclinical CRO Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of In Vitro
Figure 14. Product Picture of In Vivo
Figure 15. Global Oncology Based Preclinical CRO Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Oncology Based Preclinical CRO Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Oncology Based Preclinical CRO Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Oncology Based Preclinical CRO Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Oncology Based Preclinical CRO Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Oncology Based Preclinical CRO Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Oncology Based Preclinical CRO Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Oncology Based Preclinical CRO Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Oncology Based Preclinical CRO Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Oncology Based Preclinical CRO Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Oncology Based Preclinical CRO Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Oncology Based Preclinical CRO Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Oncology Based Preclinical CRO Sales Value (%), (2019-2030)
Figure 28. United States Oncology Based Preclinical CRO Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Oncology Based Preclinical CRO Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Oncology Based Preclinical CRO Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Oncology Based Preclinical CRO Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Oncology Based Preclinical CRO Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Oncology Based Preclinical CRO Sales Value by Application (%), 2023 VS 2030
Figure 34. China Oncology Based Preclinical CRO Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Oncology Based Preclinical CRO Sales Value by Type (%), 2023 VS 2030
Figure 36. China Oncology Based Preclinical CRO Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Oncology Based Preclinical CRO Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Oncology Based Preclinical CRO Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Oncology Based Preclinical CRO Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Oncology Based Preclinical CRO Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Oncology Based Preclinical CRO Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Oncology Based Preclinical CRO Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Oncology Based Preclinical CRO Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Oncology Based Preclinical CRO Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Oncology Based Preclinical CRO Sales Value by Application (%), 2023 VS 2030
Figure 46. India Oncology Based Preclinical CRO Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Oncology Based Preclinical CRO Sales Value by Type (%), 2023 VS 2030
Figure 48. India Oncology Based Preclinical CRO Sales Value by Application (%), 2023 VS 2030
Figure 49. Oncology Based Preclinical CRO Industrial Chain
Figure 50. Oncology Based Preclinical CRO Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
